In vitro and in vivo intracellular distribution and anti-glioblastoma effects of docetaxel-loaded nanoparticles functioned with IL-13 peptide

International Journal of Pharmaceutics

Volumn 466, Issue 1-2, 2014, Pages 8-17

  Gao, Huile ^a   Zhang, Shuang ^a   Yang, Zhi ^a   Cao, Shijie ^a   Jiang, Xinguo ^a   Pang, Zhiqing ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Docetaxel; Glioblastoma; Interleukin 13 peptide; Intracellular distribution; Targeting nanoparticles

Indexed keywords

DOCETAXEL; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR ALPHA2; NANOPARTICLE; ANTINEOPLASTIC AGENT; COUMARIN 6; COUMARIN DERIVATIVE; PEPTIDE; TAXOID; THIAZOLE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; APOPTOSIS ASSAY; ARTICLE; CELL ORGANELLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DRUG DELIVERY SYSTEM; DRUG UPTAKE; ENDOSOME; GLIOBLASTOMA; GLIOMA CELL; GOLGI COMPLEX; GROWTH INHIBITION; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; LIVER; LUNG; MALE; MICROTUBULE; MOUSE; NICK END LABELING; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; SPLEEN; TISSUE DISTRIBUTION; TRANSMISSION ELECTRON MICROSCOPY; TUMOR SPHEROID; ANIMAL; BAGG ALBINO MOUSE; BRAIN NEOPLASMS; CHEMISTRY; DRUG EFFECTS; HUMAN; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BIOLOGICAL TRANSPORT; BRAIN NEOPLASMS; CELL LINE, TUMOR; COUMARINS; DRUG DELIVERY SYSTEMS; GLIOBLASTOMA; HUMANS; INTERLEUKIN-13; MALE; MICE, INBRED BALB C; NANOPARTICLES; PEPTIDES; TAXOIDS; THIAZOLES;

EID: 84896515489     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2014.03.012     Document Type: Article

References (31)

1. S. Agarwal, R. Sane, R. Oberoi, J.R. Ohlfest, and W.F. Elmquist Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain Expert Reviews in Molecular Medicine 13 2011 e17
2. M. Demeule, D. Shedid, E. Beaulieu, M.R. Del, A. Moghrabi, P.B. Ghosn, R. Moumdjian, F. Berthelet, and R. Beliveau Expression of multidrug-resistance P-glycoprotein (MDR1) in human brain tumors International Journal of Cancer 93 2001 62 66 (Pubitemid 32539502)
3. L.A. Doyle, and D.D. Ross Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2) Oncogene 22 2003 7340 7358 (Pubitemid 37487163)
4. J. Du, W.L. Lu, X. Ying, Y. Liu, P. Du, W. Tian, Y. Men, J. Guo, Y. Zhang, R.J. Li, J. Zhou, J.N. Lou, J.C. Wang, X. Zhang, and Q. Zhang Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals Molecular Pharmaceutics 6 2009 905 917
5. R.L. Fine, J. Chen, C. Balmaceda, J.N. Bruce, M. Huang, M. Desai, M.B. Sisti, G.M. McKhann, R.R. Goodman, J.J. Bertino, A.N. Nafziger, and M.R. Fetell Randomized study of paclitaxel and tamoxifen deposition into human brain tumors: implications for the treatment of metastatic brain tumors Clinical Cancer Research 12 2006 5770 5776 (Pubitemid 44629608)
6. H. Gao, S. Pan, Z. Yang, S. Cao, C. Chen, X. Jiang, S. Shen, Z. Pang, and Y. Hu A cascade targeting strategy for brain neuroglial cells employing nanoparticles modified with angiopep-2 peptide and EGFP-EGF1 protein Biomaterials 32 2011 8669 8675
7. H. Gao, Z. Pang, S. Pan, S. Cao, Z. Yang, C. Chen, and X. Jiang Anti-glioma effect and safety of docetaxel-loaded nanoemulsion Archives of Pharmacal Research 35 2012 333 341
8. H. Gao, J. Qian, Z. Yang, Z. Pang, Z. Xi, S. Cao, Y. Wang, S. Pan, S. Zhang, W. Wang, X. Jiang, and Q. Zhang Whole-cell SELEX aptamer-functionalised poly(ethyleneglycol)-poly(epsilon-caprolactone) nanoparticles for enhanced targeted glioblastoma therapy Biomaterials 33 2012 6264 6272
9. H. Gao, Z. Yang, S. Zhang, S. Cao, S. Shen, Z. Pang, and X. Jiang Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization Scientific Reports 3 2013 2534
10. H. Gao, Z. Yang, S. Zhang, S. Cao, Z. Pang, X. Yang, and X. Jiang Glioma-homing peptide with a cell-penetrating effect for targeting delivery with enhanced glioma localization, penetration and suppression of glioma growth Journal of Controlled Release 172 2013 921 928
11. H. Gao, S. Cao, C. Chen, S. Cao, Z. Yang, Z. Pang, Z. Xi, S. Pan, Q. Zhang, and X. Jiang Incorporation of lapatinib into lipoprotein-like nanoparticles with enhanced water solubility and anti-tumor effect in breast cancer Nanomedicine (London) 8 2013 1429 1442
12. F. Gueritte-Voegelein, D. Guenard, F. Lavelle, M.T. Le Goff, L. Mangatal, and P. Potier Relationships between the structure of taxol analogues and their antimitotic activity Journal of Medicinal Chemistry 34 1991 992 998
13. S. Jiang, S.W. Rhee, P.A. Gleeson, and B. Storrie Capacity of the Golgi apparatus for cargo transport prior to complete assembly Molecular Biology of the Cell 17 2006 4105 4117 (Pubitemid 44330892)
14. S. Jones-Bolin, H. Zhao, K. Hunter, A. Klein-Szanto, and B. Ruggeri The effects of the oral, pan-VEGF-R kinase inhibitor CEP-7055 and chemotherapy in orthotopic models of glioblastoma and colon carcinoma in mice Molecular Cancer Therapeutics 5 2006 1744 1753 (Pubitemid 44323242)
15. H. Kobayashi, S. Man, C.H. Graham, S.J. Kapitain, B.A. Teicher, and R.S. Kerbel Acquired multicellular-mediated resistance to alkylating agents in cancer Proceedings of the National Academy of Sciences of the United States of America 90 1993 3294 3298 (Pubitemid 23111352)
16. A.B. Madhankumar, A. Mintz, and W. Debinski Interleukin 13 mutants of enhanced avidity toward the glioma-associated receptor, IL-13Ralpha2 Neoplasia 6 2004 15 22 (Pubitemid 38391945)
17. A.B. Madhankumar, B. Slagle-Webb, A. Mintz, J.M. Sheehan, and J.R. Connor Interleukin-13 receptor-targeted nanovesicles are a potential therapy for glioblastoma multiforme Molecular Cancer Therapeutics 5 2006 3162 3169 (Pubitemid 46092059)
18. A.B. Madhankumar, B. Slagle-Webb, X. Wang, Q.X. Yang, D.A. Antonetti, P.A. Miller, J.M. Sheehan, and J.R. Connor Efficacy of interleukin-13 receptor-targeted liposomal doxorubicin in the intracranial brain tumor model Molecular Cancer Therapeutics 8 2009 648 654
19. B.Y. Ong, S.H. Ranganath, L.Y. Lee, F. Lu, H.S. Lee, N.V. Sahinidis, and C.H. Wang Paclitaxel delivery from PLGA foams for controlled release in post-surgical chemotherapy against glioblastoma multiforme Biomaterials 30 2009 3189 3196
20. Z. Pang, W. Lu, H. Gao, K. Hu, J. Chen, C. Zhang, X. Gao, X. Jiang, and C. Zhu Preparation and brain delivery property of biodegradable polymersomes conjugated with OX26 Journal of Controlled Release 128 2008 120 127
21. Z. Pang, H. Gao, Y. Yu, J. Chen, L. Guo, J. Ren, Z. Wen, J. Su, and X. Jiang Brain delivery and cellular internalization mechanisms for transferrin conjugated biodegradable polymersomes International Journal of Pharmaceutics 415 2011 284 292
22. M.W. Pitz, A. Desai, S.A. Grossman, and J.O. Blakeley Tissue concentration of systemically administered antineoplastic agents in human brain tumors Journal of Neuro-Oncology 104 2011 629 638
23. P. Sampath, L.D. Rhines, F. DiMeco, B.M. Tyler, M.C. Park, and H. Brem Interstitial docetaxel (taxotere), carmustine and combined interstitial therapy: a novel treatment for experimental malignant glioma Journal of Neuro-Oncology 80 2006 9 17 (Pubitemid 44473256)
24. M.D. Shultz, J.C. Duchamp, J.D. Wilson, C.Y. Shu, J. Ge, J. Zhang, H.W. Gibson, H.L. Fillmore, J.I. Hirsch, H.C. Dorn, and P.P. Fatouros Encapsulation of a radiolabeled cluster inside a fullerene cage, (177)Lu(x)Lu((3-x))N@C(80): an interleukin-13-conjugated radiolabeled metallofullerene platform Journal of the American Chemical Society 132 2010 4980 4981
25. R.M. Sutherland Cell and environment interactions in tumor microregions: the multicell spheroid model Science 240 1988 177 184
26. T.A. Ten, J. Verweij, W.J. Loos, and A. Sparreboom Pharmacological effects of formulation vehicles: implications for cancer chemotherapy Clinical Pharmacokinetics 42 2003 665 685 (Pubitemid 36936530)
27. K.K. Upadhyay, A.N. Bhatt, E. Castro, A.K. Mishra, K. Chuttani, B.S. Dwarakanath, C. Schatz, J.F. Le Meins, A. Misra, and S. Lecommandoux In vitro and in vivo evaluation of docetaxel loaded biodegradable polymersomes Macromolecular Bioscience 10 2010 503 512
28. H. Xin, X. Jiang, J. Gu, X. Sha, L. Chen, K. Law, Y. Chen, X. Wang, Y. Jiang, and X. Fang Angiopep-conjugated poly(ethylene glycol)-co-poly(epsilon- caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma Biomaterials 32 2011 4293 4305
29. C. Zhan, B. Gu, C. Xie, J. Li, Y. Liu, and W. Lu Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect Journal of Controlled Release 143 2010 136 142
30. M. Zhao, M. Su, X. Lin, Y. Luo, H. He, C. Cai, and X. Tang Evaluation of docetaxel-loaded intravenous lipid emulsion: pharmacokinetics, tissue distribution, antitumor activity, safety and toxicity Pharmaceutical Research 27 2010 1687 1702
31. S. Zhou, J.D. Schuetz, K.D. Bunting, A.M. Colapietro, J. Sampath, J.J. Morris, I. Lagutina, G.C. Grosveld, M. Osawa, H. Nakauchi, and B.P. Sorrentino The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype Nature Medicine 7 2001 1028 1034 (Pubitemid 32937383)